BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25449965)

  • 1. Prevalence of myasthenia gravis in the Catalan county of Osona.
    Aragonès JM; Altimiras J; Roura P; Alonso F; Bufill E; Munmany A; Alfonso S; Illa I
    Neurologia; 2017; 32(1):1-5. PubMed ID: 25449965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis: a higher than expected incidence in the elderly.
    Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I
    Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population based epidemiological study on myasthenia gravis in Estonia.
    Oöpik M; Kaasik AE; Jakobsen J
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain).
    García Estévez DA; López Díaz LM; Pardo Parrado M; Pérez Lorenzo G; Sabbagh Casado NA; Ozaita Arteche G; Rodríguez Gómez D
    Neurologia (Engl Ed); 2023 Mar; 38(2):75-81. PubMed ID: 35249845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.
    Zivadinov R; Jurjevic A; Willheim K; Cazzato G; Zorzon M
    Neuroepidemiology; 1998; 17(5):265-72. PubMed ID: 9705586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
    Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
    Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the prevalence of familial autoimmune myasthenia gravis in a Spanish cohort.
    Salvado M; Canela M; Ponseti JM; Lorenzo L; Garcia C; Cazorla S; Gili G; Raguer N; Gamez J
    J Neurol Sci; 2016 Jan; 360():110-4. PubMed ID: 26723985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late onset forms of myasthenia gravis. Comparison with early-onset myasthenia gravis].
    Barbaud A; Carlander B; Pagès M
    Rev Neurol (Paris); 2006 Oct; 162(10):990-6. PubMed ID: 17028567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Myasthenia Gravis in Sweden 2006-2016.
    Westerberg E; Punga AR
    Brain Behav; 2020 Nov; 10(11):e01819. PubMed ID: 32869520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of myasthenia gravis in the Iberian Peninsula and Latin America].
    García-Estévez DA; Fraga-Bau A; García-Sobrino T; Mederer-Hengstl S; Pardo-Fernández J
    Rev Neurol; 2023 Jan; 76(2):59-68. PubMed ID: 36631965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epidemiology of Myasthenia Gravis in Korea.
    Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
    Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Under-diagnosis of neuromuscular diseases in patients of 80 years and older].
    Aragonès JM; Altimiras J; Molist N; Roura P; Amblàs-Novellas J
    Rev Esp Geriatr Gerontol; 2019; 54(2):99-102. PubMed ID: 30522774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
    Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
    Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.
    Andersen JB; Engeland A; Owe JF; Gilhus NE
    Eur J Neurol; 2010 Dec; 17(12):1445-50. PubMed ID: 20491896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
    Robertson NP; Deans J; Compston DA
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):492-6. PubMed ID: 9771771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and epidemiological features of myasthenia gravis in Chilean population.
    Cea G; Martinez D; Salinas R; Vidal C; Hoffmeister L; Stuardo A
    Acta Neurol Scand; 2018 Oct; 138(4):338-343. PubMed ID: 29845611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis in the county of Viborg, Denmark.
    Sørensen TT; Holm EB
    Eur Neurol; 1989; 29(3):177-9. PubMed ID: 2731568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.